Get In Touch

U.S. Antimicrobial Plastics Market: Snapshot

Antimicrobial plastics belong to a class of polymers that impede the growth of microorganisms owing to the presence of active antimicrobial agents on the polymer. Antimicrobial plastics inhibit the growth of microorganisms in a variety of products that they enclose or contain, thus playing a big role in extending the quality and shelf life of the products. Moreover, antimicrobial plastics help in curtailing infections and preventing illnesses by resisting the growth of disease-causing pathogens.

Owing to their multifarious applications, antimicrobial plastics have witnessed a significant rise in demand in the past few years, especially in industries such as healthcare, packaging, and personal care. The trend is likely to remain strong in the near future as well, with their rising set of applications in the fields of biomedical devices and implants expected lead to a massive rise in growth opportunities for antimicrobial plastics. The U.S. market for antimicrobial plastics accounts for a large share in the global market and is one of the key contributors in terms of revenue as well as technological advancements owing to the vast research and development activities.

Transparency Market Research estimates that the U.S. antimicrobial plastics market will exhibit a 9.3% CAGR from 2014 to 2020, rising from a valuation of US$662.3 mn in 2013 to a revenue opportunity of nearly US$1,227 mn by 2020.

Healthcare to Remain Leading Application Segment for Antimicrobial Plastics in the U.S.

The report segments the U.S. market for antimicrobial plastics on the basis of application into electronic and consumer appliances, packaging, personal care, building and construction, healthcare, automotive, and other smaller applications such as waste bins and sportswear. Of these, the healthcare industry accounted for the dominant 44% share in the U.S. antimicrobial plastics market in 2013. Applications in the packaging and electronic and consumer appliances segments followed those in the healthcare sector in terms of revenue contribution to the overall market in the said year. The trend is also expected to remain strong over the next few years.

Factors such as increasing number of healthcare regulations and the rising awareness regarding the increased prevalence of hospital-acquired infections are expected to continue to fuel the demand for antimicrobial plastics in the U.S. healthcare sector. While the healthcare industry will continue to be the leading consumer of antimicrobial plastics in the U.S., applications across the personal care and packaging sectors are also expected to remain lucrative. The thriving personal care packaging sector, which includes the packaging of skin care and hair care products and cosmetics, coupled with the packaging of food and beverages and pharmaceuticals is expected to help ramp up the demand for antimicrobial plastics in the U.S.

Focus on New Application Areas Could Benefit Companies Sustain in Fragmented Marketplace

The U.S. market for antimicrobial plastics features a largely fragmented competitive landscape owing to the large number of manufacturers in the country. The leading three companies in the market accounted collectively for merely over 35% of the overall market in 2013; the level of competition is intense and is expected to remain so in the near future as well. Moreover, the market bestows a low threat of forward as well as backward integration by antimicrobial plastic manufacturers as the market features a complex manufacturing environment and is highly capital intensive.

Companies in the market could benefit from the development of innovative product varieties and focus on business expansion across new and profitable application areas. For expansion in the personal care segment, expected to account for a vast share in the overall market through the forecast period, products that increase the shelf-life and aesthetic appeal of products, could fuel demand. Some of the leading companies in the market are AkzoNobel, The Dow Chemical Company, Sherwin-Williams, BASF, Bayer, DuPont and Lonza.

Antimicrobial plastics are molded polymers infused with antimicrobials to inhibit the growth of various harmful microorganisms such as fungi and bacteria. Antimicrobial plastics are used in various industries such as healthcare, automotives, building & construction, electronics, packaging and consumer goods. Additionally, they are used in niche applications such as pipes, plastic water storage containers, waste bins and lids. Rising awareness among consumers regarding good health and cleanliness is expected to be one of the primary factors driving the growth of the antimicrobial plastics market. 
 
Antimicrobial plastics are increasingly used in packaging and electronic appliances as these products are highly susceptible to germs. This may result in transfer of infections. Additionally, growth in electronics, healthcare and packaging industries is anticipated to boost demand for antimicrobial plastics. Higher willingness of consumers to increase expenditure on products with antimicrobial properties is estimated to contribute significantly to the growth of the market.
 
The report on U.S.antimicrobial plastics market report forecasts and analyzes the antimicrobial plastics market on a regional level. The forecast demand on the global level is based on volume (tons) and revenue (USD million) for the period ranging from 2014 to 2020. The study on U.S. antimicrobial plastics market outlines drivers and restraints of the polyester market and their impact on market growth during the mentioned time period. Additionally, the study includes opportunities available for the market on the regional and level and their effect during the said forecast period.
 
All plastics infused with antimicrobials have been classified as antimicrobial plastics under the scope of this study. Personal care includes packaging of personal care products. Packaging of healthcare products has been classified under the packaging segment. Packaging typically includes foods, beverages and pharmaceuticals. In other words, the segment includes all types of packaging, except for personal care products.
 
We have conducted a detailed analysis of the value chain in order to help understand the antimicrobial plastics market better. Furthermore, Porter’s five forces model provides a better understanding of the intensity of competition in the market. The study comprises a market attractiveness analysis, wherein key applications are benchmarked based on their market size, growth rate and general attractiveness.
 
For the research report, we conducted in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents the bulk of research efforts, supplemented by an extensive secondary research. We reviewed key players’ product literature, annual reports, press releases and relevant documents for competitive analysis and market understanding. Secondary research also includes a search of recent trade, technical writing, internet sources, and statistical data from government websites, trade associations and agencies. This has proven to be the most reliable, effective and successful approach for obtaining precise market data, capturing industry participants’ insights and recognizing business opportunities. 
 
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the U.S. market. Key players profiled in the report include AkzoNobel N.V, BASF SE, Bayer AG, Bayer AG, E. I. du Pont de Nemours and Company, Lonza Group AG, Momentive Performance Materials Inc, Sinanen Zeomic Co Ltd, Sciessent LLC, Sherwin-Williams and Teknor Apex. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments.
 
The study provides a decisive view of the antimicrobial plastics market by segmenting the market based on applications. All the applications have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. The regional segmentation includes the current and forecast demand for U.S. This segmentation includes demand for individual applications in the particular region. For the purpose of this study, the antimicrobial plastics market has been segmented based on applications. Application segments have been analyzed and forecasted based on current trends at the regional level for the period between 2014 and 2020. The market has been segmented as below:
 
U.S. Antimicrobial Plastics Market – Application Segment Analysis
  • Electronics & consumer appliances
  • Personal care
  • Packaging
  • Automotive
  • Building & construction
  • Healthcare
  • Others (Includes sportswear, waste bins, etc.)

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

 
Chapter 1 Preface
1.1 Report description
1.2 Market segmentation
      1.2.1 U.S. antimicrobial plastics market segmentation
1.3 Research methodology
      1.3.1 Assumptions
 
Chapter 2 Executive Summary
2.1 U.S. antimicrobial plastics market, 2013 – 2020 (Tons) (USD Million)
2.2 U.S. antimicrobial plastics: Market snapshot (2013 and 2020)
 
Chapter 3 Antimicrobial Plastics – Industry Analysis
3.1 Introduction
3.2 Value chain analysis
3.3 Market drivers
      3.3.1 Growing demand for medical devices to augment market for antimicrobial plastics
              3.3.1.1 U.S. medical devices market, 2013 – 2020 (USD Billion)
      3.3.2 High rate of hospital-acquired infections to fuel demand for antimicrobial plastics
              3.3.2.1 U.S. hospital-acquired infection (HAIs) breakdown by types of infections, 2011 (%)
      3.3.3 Increasing demand for antimicrobial plastics in packaging
              3.3.3.1 U.S. plastic packaging market, 2013 – 2020 (USD Billion)
3.4 Market restraints
      3.4.1 Volatility in prices of raw materials to impact market growth
              3.4.1.1 Global silver prices, 2009 – 2014 (USD/kg)
3.5 Market opportunities
      3.5.1 Product innovation to open opportunities for market growth
3.6 U.S. regulatory scenario
3.7 Porter’s five forces analysis
      3.7.1 Bargaining power of suppliers
      3.7.2 Bargaining power of buyers
      3.7.3 Threat of new entrants
      3.7.4 Threat of substitutes
      3.7.5 Degree of competition
3.8 Market attractiveness analysis
3.9 Company market share analysis
 
Chapter 4 Antimicrobial Plastics Market – Application Analysis
4.1 U.S. antimicrobial plastics market: application overview
      4.1.1 U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
4.2 U.S antimicrobial plastics market, by application
      4.2.1 Electronics & consumer appliances
              4.2.1.1 U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 – 2020 (Tons) (USD Million)
      4.2.2 Personal care
              4.2.2.1 U.S antimicrobial plastics market for personal care, 2013 – 2020 (Tons) (USD Million)
      4.2.3 Packaging
              4.2.3.1 U.S. antimicrobial plastics market for packaging, 2013 – 2020 (Tons) (USD Million)
      4.2.4 Automotives
              4.2.4.1 U.S. antimicrobial plastics market for automotives, 2013 – 2020 (Tons) (USD Million)
      4.2.5 Building & construction
              4.2.5.1 U.S. antimicrobial plastics market for building & construction, 2013 – 2020 (Tons) (USD Million)
      4.2.6 Healthcare
              4.2.6.1 U.S. antimicrobial plastics market for healthcare, 2013 – 2020 (Tons) (USD Million)
      4.2.7 Others
              4.2.7.1 U.S. antimicrobial plastics market for other applications, 2013 – 2020 (Tons) (USD Million)
 
Chapter 5 Company Profiles
5.1 AkzoNobel N.V.
      5.1.1 Company overview
      5.1.2 Product portfolio
      5.1.3 Financial overview
      5.1.4 Business strategy
      5.1.5 SWOT analysis
      5.1.6 Recent developments
5.2 BASF SE
      5.2.1 Company overview
      5.2.2 Product portfolio
      5.2.3 Financial overview
      5.2.4 Business strategy
      5.2.5 SWOT analysis
      5.2.6 Recent developments
5.3 Bayer AG
      5.3.1 Company overview
      5.3.2 Product portfolio
      5.3.3 Financial overview
      5.3.4 Business strategy
      5.3.5 SWOT analysis
      5.3.6 Recent developments
5.4 Diamond Vogel
      5.4.1 Company overview
      5.4.2 Product portfolio
      5.4.3 Business strategy
      5.4.4 SWOT analysis
      5.4.5 Recent developments
5.5 E. I. du Pont de Nemours and Company
      5.5.1 Company overview
      5.5.2 Product portfolio
      5.5.3 Financial overview
      5.5.4 Business strategy
      5.5.5 SWOT analysis
      5.5.6 Recent developments
5.6 Ishizuka Glass Co. Ltd.
      5.6.1 Company overview
      5.6.2 Product portfolio
      5.6.3 Financial overview
      5.6.4 Business strategy
      5.6.5 SWOT analysis
      5.6.6 Recent developments
5.7 Lonza Group AG
      5.7.1 Company overview
      5.7.2 Product portfolio
      5.7.3 Financial overview
      5.7.4 Business strategy
      5.7.5 SWOT analysis
      5.7.6 Recent developments
5.8 Momentive Performance Materials Inc.
      5.8.1 Company overview
      5.8.2 Product portfolio
      5.8.3 Financial overview
      5.8.4 SWOT analysis
      5.8.5 Recent developments
5.9 Sinanen Zeomic Co Ltd
      5.9.1 Company overview
      5.9.2 Product portfolio
      5.9.3 Business strategy
      5.9.4 SWOT analysis
      5.9.5 Recent developments
5.10 Sciessent LLC
      5.10.1 Company overview
      5.10.2 Product portfolio
      5.10.3 Business strategy
      5.10.4 SWOT analysis
      5.10.5 Recent developments
5.11 Sherwin-Williams
      5.11.1 Company overview
      5.11.2 Product portfolio
      5.11.3 Financial overview
      5.11.4 Business strategy
      5.11.5 SWOT analysis
      5.11.6 Recent developments
5.12 Teknor Apex
      5.12.1 Company overview
      5.12.2 Product portfolio
      5.12.3 Business strategy
      5.12.4 SWOT analysis
5.13 The Dow Chemical Company
      5.13.1 Company overview
      5.13.2 Product portfolio
      5.13.3 Financial overview
      5.13.4 Business strategy
      5.13.5 SWOT analysis
List of Tables
 
TABLE 1 Antimicrobial plastics: U.S. snapshot
TABLE 2 Drivers for antimicrobial plastics market: Impact analysis
TABLE 3 Restraints for antimicrobial plastics market: Impact analysis
List of Figures 
 
FIG. 1 U.S. antimicrobial plastics market segmentation
FIG. 2 U.S. antimicrobial plastics market, 2013 – 2020 (Tons) (USD Million)
FIG. 3 U.S. antimicrobial plastics market: Value chain analysis
FIG. 4 U.S. medical devices market, 2013 – 2020 (USD Billion)
FIG. 5 U.S. hospital acquired infection (HAIs) breakdown by types of infections, 2011 (%)
FIG. 6 U.S. plastic packaging market, 2013 – 2020 (USD Billion)
FIG. 7 Global silver prices, 2009 – 2014 (USD/kg)
FIG. 8 Porter’s five forces analysis
FIG. 9 U.S. antimicrobial plastics: Market attractiveness analysis
FIG. 10 U.S. antimicrobial plastics: Company market share analysis (2013)
FIG. 11 U.S. antimicrobial plastics market volume share, by application, 2013 and 2020
FIG. 12 U.S. antimicrobial plastics market for electronics & consumer appliances, 2013 -2020 (Tons) (USD Million)
FIG. 13 U.S. Antimicrobial Plastics Market for Personal Care, 2013 – 2020 (Tons) (USD Million)
FIG. 14 U.S. antimicrobial plastics for packaging, 2013 – 2020 (Tons) (USD Million)
FIG. 15 U.S. antimicrobial plastics for automotives, 2013 – 2020 (Tons) (USD Million)
FIG. 16 U.S. antimicrobial plastics for building & construction, 2013 – 2020 (Tons) (USD Million)
FIG. 17 U.S. antimicrobial plastics for healthcare, 2013 – 2020 (Tons) (USD Million)
FIG. 18 U.S. antimicrobial plastics for other applications, 2013 – 2020 (Tons) (USD Million)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Us Antimicrobial Plastics Market